“Behind every COVID-19 test sample is a person worried about their results”
04 Sep 2020Meet the volunteer scientists who turn swab samples into diagnoses – again and again and again.
Meet the volunteer scientists who turn swab samples into diagnoses – again and again and again.
Operations Director Karl Wilson has helped lead a herculean effort to transform a standard laboratory into a bespoke testing centre, to aid the national response against COVID-19. For him, there was never any question about whether we should - or could - do this.
As part of the UK Government’s announcement of a new five pillar plan to boost testing for COVID-19, AstraZeneca, GSK and the University of Cambridge have formed a joint collaboration to take action to support this national effort.
Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge University for more than two decades. What are the secrets of their success?
Chris Skidmore, Minister for Universities, Science, Research and Innovation, announced on 10 July 2019 a £30 million award to the University of Cambridge to support the new Cambridge Heart and Lung Research Institute (HLRI).
We spoke with Cambridge’s most recent Nobel Laureate about decades of research, spin-outs, pharma giants and the booming life sciences cluster in Greater Cambridge.
The 2019 Cambridge Science Festival is set to host more than 350 events as it explores a range of issues that affect today’s world, from challenges around climate change policy, improving safety and quality in healthcare, and adolescent mental health, to looking at what the next 25 years holds for us and whether quantum computers can change the world.
Cambridge celebrated the first ever LGBTSTEM Day on 5 July – recognising all those who work in science, technology, engineering and medicine and who identify as lesbian, gay, bisexual, transgender and other minority gender identities and sexual orientations.
Tony Kouzarides is passionate about ecosystems: well-balanced communities that flourish on mutual and dynamic interactions. But the ecosystems that excite him are not made up of plants, animals and environments. They’re made up of experts.
When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.